Study assessing combination therapy of Andexanet alfa after 4-factor Prothrombin-complex-concentrate for intracranial hemorrhage
Latest Information Update: 24 Aug 2022
At a glance
- Drugs Andexanet alfa (Primary) ; Prothrombin complex concentrate (Primary)
- Indications Intracranial haemorrhages
- Focus Adverse reactions
Most Recent Events
- 24 Aug 2022 New trial record
- 01 Aug 2022 Results published in the Journal of Thrombosis and Thrombolysis